Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/6821 stock hub

HKG/6821 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/6821is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

50B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/6821

In the news

Latest news · HKG/6821

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.3

P25 11.7P50 18.9P75 41.4

Trailing P/E39.6

P25 10.7P50 17.9P75 38.5

ROE6.3

P25 -14.7P50 2P75 9.4

ROIC9.8

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/6821 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

CNY

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	10,617
Employees Change	1,022%
Employees Change Percent	10.65
Enterprise value	HKD 41.4B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100004Z06
Last refreshed	2026-05-10
Market cap	HKD 50B
Price	HKD 101
Price currency	HKD
Rev Per Employee	742,020.35x
Sector	Healthcare
Sic	2834
Symbol	hkg/6821
Website	https://www.asymchem.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.52%
EV Earnings	32.8x
EV/EBIT	30.79x
EV/EBITDA	20.87x
EV/FCF	334.54x
EV/Sales	5.19x
FCF yield	0.25%
Forward P/E	28.31x
P/B ratio	2.45x
P/E ratio	39.64x
P/S ratio	6.35x
PE Ratio10 Y	49.14x
PE Ratio3 Y	26.01x
PE Ratio5 Y	39.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.85%
EBITDA Margin	24.02%
FCF margin	1.57%
Gross margin	41.3%
Gross Profit	HKD 3.3B
Gross Profit Growth	16.44%
Gross Profit Growth Q	18.23%
Gross Profit Growth3 Y	-16.9%
Gross Profit Growth5 Y	12.91%
Net Income	HKD 1.3B
Net Income Growth	11.75%
Net Income Growth Q	-6.82%
Net Income Growth Years	1%
Net Income Growth3 Y	-31.34%
Net Income Growth5 Y	7.72%
Pretax Margin	18.22%
Profit Margin	16.02%
Profit Per Employee	HKD 118,868
Profitable Years	15
ROA	3.64
Roa5y	6.03
ROCE	6.26
ROE	6.28
Roe5y	12.06
ROIC	9.83
Roic5y	18.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	88.27%
Cagr3y	2.3%
Div CAGR3	-15.37%
EPS Growth	10.03
EPS Growth Q	-5.62
EPS Growth Years	1
EPS Growth3 Y	-30.77
EPS Growth5 Y	6.12
FCF Growth	-32.18%
FCF Growth Q	-13.67%
FCF Growth3 Y	-65.02%
OCF Growth	22.42%
OCF Growth Q	17.21%
OCF Growth10 Y	27.87%
OCF Growth3 Y	-30.3%
OCF Growth5 Y	18.92%
Revenue Growth	16.56x
Revenue Growth Q	16.91x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	-12.7x
Revenue Growth5 Y	15.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.35
Assets	HKD 23.5B
Cash	HKD 8.9B
Current Assets	HKD 13.5B
Current Liabilities	HKD 2.4B
Debt	HKD 333.1M
Debt EBITDA	HKD 0.17
Debt Equity	HKD 0.02
Debt FCF	HKD 2.69
Equity	HKD 20.4B
Interest Coverage	90.91
Liabilities	HKD 3.1B
Long Term Assets	HKD 10B
Long Term Liabilities	HKD 745.2M
Net Cash	HKD 8.5B
Net Cash By Market Cap	HKD 17.06
Net Cash Growth	0.04%
Net Debt EBITDA	HKD -4.51
Net Debt Equity	HKD -0.42
Net Debt FCF	HKD -68.96
Tangible Book Value	HKD 19.8B
Tangible Book Value Per Share	HKD 54.55
WACC	5.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.69
Inventory Turnover	2.9
Net Working Capital	HKD 2.2B
Quick ratio	4.74
Working Capital	HKD 11B
Working Capital Turnover	HKD 0.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.56%
Dividend Growth	-39.18%
Dividend Growth Years	0%
Dividend per share	HKD 1.2
Dividend Years	4
Dividend Yield	1.16%
Ex Div Date	2025-06-25
Last Dividend	HKD 1.2
Payout Frequency	Annual
Payout Ratio	35.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	88.18%
200-day SMA	88.68
3Y total return	7.07%
50-day SMA	89.45
50-day SMA vs 200-day SMA	50over200
All Time High	277.1
All Time High Change	-63.56%
All Time High Date	2021-12-10
All Time Low	37.6
All Time Low Change	168.62%
All Time Low Date	2024-09-10
ATR	6.43
Beta	0.16
Ch YTD	41.85
High	106.6
High52	116.6
High52 Date	2025-07-29
High52ch	-13.38%
Low	98.35
Low52	52
Low52 Date	2025-05-12
Low52ch	94.23%
Ma50ch	12.91%
Price vs 200-day SMA	13.9%
RSI	53.7
RSI Monthly	55.16
RSI Weekly	64.07
Sharpe ratio	1.24x
Sortino ratio	2.18
Total Return	-0.39%
Tr YTD	41.85
Tr1m	-1.46%
Tr1w	-2.7%
Tr3m	20.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 1.3B
Operating Income Growth	62.13
Operating Income Growth Q	33.03
Operating Income Growth3 Y	-28.9
Operating Income Growth5 Y	7.52
Operating margin	16.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	219,489,973%
Net Borrowing	-72,375,721.7
Shares Insiders	4.34%
Shares Institutions	26.28%
Shares Qo Q	9%
Shares Yo Y	1.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 123.7M
Average Volume	665,763.75x
Bv Per Share	56.33
CAPEX	HKD -1.6B
Ch1m	-1.46
Ch1w	-2.7
Ch1y	85.15
Ch3m	20.53
Ch3y	-0.49
Ch6m	20.81
Change	-4.36%
Change From Open	-3.72
Close	105.6
Days Gap	-0.66
Depreciation Amortization	572,256,905.6
Dollar Volume	69,548,600
Earnings Date	2026-08-27
EBIT	HKD 1.3B
EBITDA	HKD 1.9B
EPS	HKD 3.53
F Score	5
FCF	HKD 123.7M
FCF EV Yield	0.3x
Financing CF	-390,861,406
Fiscal Year End	December
Founded	1,998
Goodwill	168,339,456.3
Graham Number	48.61119
Graham Upside	-51.87
Income Tax	HKD 181M
Investing CF	-1,618,746,112
Is Primary Listing	0
Last Earnings Date	2026-03-30
Last Report Date	2026-03-31
Last Split Date	2022-07-11
Last Split Type	Forward
Lynch Fair Value	HKD 19.67
Lynch Upside	-80.53
Ma150	85.6
Ma150ch	17.99%
Ma20	100.5
Ma20ch	0.48%
Net CF	-484,515,529
Next Earnings Date	2026-08-27
Open	104.9
P FCF Ratio	404.3
P OCF Ratio	29.64
Payment Date	2025-07-25
Position In Range	32.12
Ppne	7,824,233,439.4
Price Date	2026-05-08
Price EBITDA	HKD 26.44
Ptbv Ratio	2.53
Relative Volume	1.01x
Revenue	7,878,030,031x
Tax By Revenue	2.3x
Tax Rate	12.62%
Tr6m	20.81%
Volume	688,600
Z Score	9.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/6821 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$1.20 annual per share

Payout ratio

+35.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-0.4%

Next ex-dividend date: 2025-06-25

Performance

HKG/6821 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/6821?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.3%

Share of float held by funds and institutions

Insider ownership

+4.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.6%

Negative means the company is buying back shares.

Technical

HKG/6821 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.7

Neutral momentum band

Price vs 200-day MA

+13.9%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/6821

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/6821 stock rating?

hkg/6821 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/6821 analysis?

The full report lives at /stocks/hkg/6821/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/6821?

The latest report frames hkg/6821 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/6821 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.